Literature DB >> 29580934

3D treatment planning on helical tomotherapy delivery system.

Cheng B Saw1, Leah Katz2, Carol Gillette2, Lawrence Koutcher2.   

Abstract

The helical tomotherapy is a technologically advanced radiation dose delivery system designed to perform intensity-modulated radiation therapy (IMRT). It is mechanistically unique, based on a small 6-MV linear accelerator mounted on a ring gantry that rotates around the patient while the patient moves through a bore, ultimately yielding a helical path of radiation dose delivery. The helical pattern of dose delivery differentiated tomotherapy from other contemporary radiation therapy systems at the time of its inception. The accompanying 3-dimensional (3D) treatment planning system has been developed to solely support this specific type of dose delivery system. The treatment planning system has 2 modules identified as TomoHelical and TomoDirect to perform IMRT and conformal radiation therapy, respectively. The focus of this work within the scope of this special issue on 3D treatment planning systems is to assess the use of planning tools to generate treatment plans for helical tomotherapy. Clinical examples are used throughout to demonstrate the quality and differences of various clinical scenarios planned with tomotherapy.
Copyright © 2018 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Intensity-modulated radiation therapy; Radiosurgery; Stereotactic ablative radiation therapy; Stereotactic body radiation therapy; Tomotherapy

Mesh:

Year:  2018        PMID: 29580934     DOI: 10.1016/j.meddos.2018.02.012

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  1 in total

1.  A first report of tumour-tracking radiotherapy with helical tomotherapy for lung and liver tumours: A double case report.

Authors:  Wataru Okada; Hiroshi Doi; Masao Tanooka; Keisuke Sano; Kenji Nakamura; Yusuke Sakai; Mayuri Shibata; Masahiro Tanaka
Journal:  SAGE Open Med Case Rep       Date:  2021-06-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.